image header

Investor FAQ

Investor FAQ

Show All
Where is ALX Oncology headquartered?

866 Malcolm Road, Suite 100,
Burlingame, CA 94010

Where is ALX Oncology incorporated?


When was ALX Oncology founded?


Which stock exchange are ALX Oncology shares traded on and what is the company’s ticker?

ALX Oncology’s stock is traded on the Nasdaq Global Select Market under the ticker “ALXO.”

When did the company go public?

ALX Oncology began trading common stock shares on the NASDAQ Global Market on July 17th, 2020.

When does ALX Oncology’s fiscal year end?

ALX Oncology’s fiscal year ends on December 31.

Who is ALX Oncology’s independent registered public accounting firm?


What is ALX Oncology’s CUSIP number?

ALX Oncology's CUSIP number is 00166B105.

How can I purchase ALX Oncology shares?

Shares of ALX Oncology’s common stock can be purchased by contacting a securities broker of your choice.

Does ALX Oncology have a direct stock purchase plan?

ALX Oncology does not currently offer a direct stock purchase plan.

Does ALX Oncology pay dividends and have a dividend reinvestment program?


Who is ALX Oncology’s transfer agent?

Computershare Trust Company, NA
150 Royall Street
Canton, Massachusetts 02021
(800) 962-4284

How do I report a change of mailing address?

If the shares are held in your name, you must contact ALX Oncology’s transfer agent, Computershare. If your shares are held in street name, you must contact your broker to update your address.

How can I get a copy of ALX Oncology’s annual report or any other investor material?

Quarterly & Annual reports and other investor materials are available under “Filings” in the “Investors” section of ALX Oncology’s corporate website. Additionally, all SEC filings can also be accessed directly from the SEC at

How can I sign up to receive ALX Oncology press releases and other company information?

Please visit the “Investors” section of ALX Oncology’s corporate website and choose the “Email Alerts” link under “Info” to be added to the ALX distribution list.

Whom should I contact if I have additional questions?

For media inquiries, please send an email to For investor inquiries, please send an email to